About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,979 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,979 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6181-6200 of 18,979 trials

CompletedRelapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in…NCT04410991·Cullman, Alabama and 185 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedGlobal Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)The purpose of this study is to evaluate the efficacy and safety of two different doses of MK-2060 (a monoclonal antibody against Factor XI) in end stage renal disease (ESRD)…NCT05027074·Huntsville, Alabama and 119 others

WithdrawnMirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 MonthsResearchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH).NCT06904274·Phoenix, Arizona and 37 others

CompletedSix Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal NeurostimulatorIn this study, the safety and effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator after 180 days of use in participants with aqueous tear deficiency will be evaluated.NCT02526290·Phoenix, Arizona and 2 others

UnknownSafety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal MenTo evaluate the safety and efficacy of fispemifene in men with secondary hypogonadism and sexual side effects.NCT02443090·Little Rock, Arkansas and 15 others

CompletedPhase III Randomized Study of UT-15 in Patients With Primary Pulmonary HypertensionOBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.NCT00004497·Torrance, California and 6 others

RecruitingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsThis is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of…NCT06784193·Gilbert, Arizona and 24 others

Active not recruitingA Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathyThe goal of this trial is to learn about the effect of PRAX-222 in pediatric participants with early onset SCN2A developmental and epileptic encephalopathy (DEE), aged 2 to 18…NCT05737784·Memphis, Tennessee and 2 others

CompletedAssessment of KAN-101 in Celiac Disease (ACeD)A safety study of KAN-101 in patients with celiac disease. The study has two parts: 1.NCT04248855·Anaheim, California and 12 others

CompletedA Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaThe purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.NCT05552326·Birmingham, Alabama and 204 others

CompletedA Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic NeuropathyPhase 2/3 open-label trial to assess the safety and tolerability of long-term treatment with lacosamide (SPM 927) in subjects with painful diabetic neuropathy.NCT00235443·Anniston, Alabama and 83 others

Active not recruitingConsent for Use of Stored Patient Specimens for Future TestingThe purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic…NCT00031408·Los Angeles, California and 62 others

CompletedEfficacy & Safety of Inhaled Insulin in Type 1 DiabetesTo determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetesNCT00308308·Mobile, Alabama and 128 others

CompletedA Phase 1 Study in Participants With Advanced CancerThe primary purpose of Parts A and B of this study is to evaluate the safety and toxicity of prexasertib (an inhibitor of checkpoint kinase 1\[chk 1\]) in participants with…NCT01115790·Sarasota, Florida and 4 others

CompletedPrimary Care Child Obesity Intervention Targeting ParentsChild overweight has become one of today's most important public health concerns.NCT01729910·Johnson City, Tennessee

CompletedA Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)The purpose of this study is to evaluate the overall response rate (ORR) of pemigatinib as a monotherapy in the treatment of metastatic or surgically unresectable urothelial…NCT02872714·Tucson, Arizona and 95 others

CompletedA Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial SpondyloarthritisThe purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects…NCT03928704·Mesa, Arizona and 82 others

CompletedA Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast CancerThis was a Phase 1/2 dose escalation and cohort expansion study and assessed the safety, tolerability and anti-tumor activity of ARV-471 alone and in combination with palbociclib…NCT04072952·Palo Alto, California and 15 others

CompletedA Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced CancerThe main purpose of this study is to investigate the safety of prexasertib in combination with other anti-cancer drugs (cisplatin, cetuximab, pemetrexed, fluorouracil or…NCT02124148·Sarasota, Florida and 4 others

CompletedProspective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With OcrelizumabOpen-label, prospective, single-arm, multi-center study to assess disease activity and biomarker of neuronal damage in minority patients (self-identified Black or African American…NCT04377555·Phoenix, Arizona and 27 others

PreviousPage 310 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee